Our vectorized base editor also presents advantage in low-cost production and scalability over previous ex vivo mouse studies using RNP or mRNA electroporation to transfect CD34+ cells from SCD patients, which achieved ∼80% conversion of HBBS to HBBG.10 The gene discussed is CD34; the disease is Schnyder corneal dystrophy.